“Radiation from C-arm procedures may increase the risk of brain cancer, cataracts, strokes and atherosclerosis, and with over 17 million fluoroscopic procedures in the U.S. every year, the ControlRad Trace is the only system available that can be utilized in each one,” says Chris Fair, ControlRad executive vice president and president, Mobile C-arm division. “Regardless of whether it is a spine or orthopedic procedure, pain management or urology case, our technology reduces radiation exposure and protects those who are saving the lives of others, like Dr. Cappuccino.”
About ControlRad
Ad Statistics
Times Displayed: 21862
Times Visited: 433 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
ControlRad is a privately held medical technology company developing innovative products that dramatically reduce the radiation exposure from fluoroscopically guided procedures (FGP) for patients and healthcare professionals. ControlRad’s products are designed to improve safety without compromising image quality or workflow. They include an integrated set of proprietary components, which optimize the X-ray beam to deliver optimal image quality in the clinically relevant region while maintaining appropriate resolution in the periphery. ControlRad is headquartered in Atlanta, Georgia, and has engineering development facilities in Kfar Saba, Israel.
Back to HCB News
